Accelmed Partners II L.P.'s Form 4 filing
NeuroPace Inc (NPCE) · filed Nov 23, 2022
- Accession no.
- 0000899243-22-036949
- Filed
- Nov 23, 2022
- Trade date
- Nov 21-22, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $585.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Accelmed Partners II L.P.CIK 0001807256 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 | Common Stock | PPurchaseAcquired | +327,893 | $1.50 | +$491,839.5 | 4,370,550 | Direct | |
| Nov 22, 2022 | Common Stock | PPurchaseAcquired | +62,398 | $1.50 | +$93,597 | 4,432,948 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.